{"id":"W1975663485","doi":"10.1056/nejmoa1203858","title":"Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":1630,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"Hjärt-Lungfonden; AFA Försäkring; University of Oxford; Novo Nordisk; Sanofi; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline; Amgen","keywords":"Basal insulin; Basal (medicine); Insulin; Internal medicine; Medicine; Endocrinology; Diabetes mellitus; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02110944816656882,"score_gpt":0.2843261207878946,"score_spread":0.2632166726213258,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}